c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC, Hsiao JR, Jiang SS, Chang JY, Chu PY, Liu KJ, Fang HL, Lin LM, Chen HH, Huang YW, Chen YT, Tsai FY, Lin SF, Chuang YJ, Kuo CC.
Tang YC, et al. Among authors: lin lm, lin sf.
Theranostics. 2021 Mar 11;11(11):5232-5247. doi: 10.7150/thno.53417. eCollection 2021.
Theranostics. 2021.
PMID: 33859744
Free PMC article.